Does dual vs. triple antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation lower the risk of bleeding at the cost of increased risk of ischemic events?

Kartik Gupta; Shane P. Prejean; Muthiah Vaduganathan; Harsh Golwala; Thomas Evan Watts; Sudeep R. Aryal; Gregory von Mering; Oscar Julian Booker; Mustafa I. Ahmed; Navkaranbir S. Bajaj

doi:10.1016/j.ijcha.2019.100404

Does dual vs. triple antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation lower the risk of bleeding at the cost of increased risk of ischemic events?

Kartik Gupta, Shane P. Prejean, Muthiah Vaduganathan, Harsh Golwala, Thomas Evan Watts, Sudeep R. Aryal, Gregory von Mering, Oscar Julian Booker, Mustafa I. Ahmed, Navkaranbir S. Bajaj

Knight Cardiovascular Institute

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Article number	100404
Journal	IJC Heart and Vasculature
Volume	24
DOIs	https://doi.org/10.1016/j.ijcha.2019.100404
State	Published - Sep 2019

Keywords

Antithrombotic therapy
Atrial fibrillation
Bleeding
Percutaneous coronary intervention
Stent thrombosis

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1016/j.ijcha.2019.100404

Cite this

Gupta, K., Prejean, S. P., Vaduganathan, M., Golwala, H., Watts, T. E., Aryal, S. R., von Mering, G., Booker, O. J., Ahmed, M. I., & Bajaj, N. S. (2019). Does dual vs. triple antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation lower the risk of bleeding at the cost of increased risk of ischemic events? IJC Heart and Vasculature, 24, Article 100404. https://doi.org/10.1016/j.ijcha.2019.100404

Does dual vs. triple antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation lower the risk of bleeding at the cost of increased risk of ischemic events? / Gupta, Kartik; Prejean, Shane P.; Vaduganathan, Muthiah et al.
In: IJC Heart and Vasculature, Vol. 24, 100404, 09.2019.

Research output: Contribution to journal › Letter › peer-review

Gupta, K, Prejean, SP, Vaduganathan, M, Golwala, H, Watts, TE, Aryal, SR, von Mering, G, Booker, OJ, Ahmed, MI & Bajaj, NS 2019, 'Does dual vs. triple antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation lower the risk of bleeding at the cost of increased risk of ischemic events?', IJC Heart and Vasculature, vol. 24, 100404. https://doi.org/10.1016/j.ijcha.2019.100404

@article{a5ff36b81d994073b66414c744393aa2,

title = "Does dual vs. triple antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation lower the risk of bleeding at the cost of increased risk of ischemic events?",

keywords = "Antithrombotic therapy, Atrial fibrillation, Bleeding, Percutaneous coronary intervention, Stent thrombosis",

author = "Kartik Gupta and Prejean, {Shane P.} and Muthiah Vaduganathan and Harsh Golwala and Watts, {Thomas Evan} and Aryal, {Sudeep R.} and {von Mering}, Gregory and Booker, {Oscar Julian} and Ahmed, {Mustafa I.} and Bajaj, {Navkaranbir S.}",

note = "Funding Information: Dr. Bajaj is supported by the American College of Cardiology Presidential Career Development Award, the Walter B. Frommeyer, Jr., Fellowship in Investigative Medicine, and National Center for Advancing Translational Research of the National Institutes of Health under award number UL1TR001417. ",

year = "2019",

month = sep,

doi = "10.1016/j.ijcha.2019.100404",

language = "English (US)",

volume = "24",

journal = "IJC Heart and Vasculature",